To ensure that future patients living with CLD will be correctly diagnosed and treated, we herein suggest a classification of pathogenic leptin variants into 3 subtypes based on whether leptin synthesis and/or secretion, leptin receptor binding, or leptin receptor activation are affected. This evidence concerns the gene LEP and congenital secretory chloride diarrhea 1.